“Successful Early Rescue with Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients with ‘No Washout Period’: A Real-World Clinical Experience in A Case Series and Literature Review”, acmcr, vol. 10, no. 1, pp. 1–5, Jan. 2026, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/23020